{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:00:45Z","timestamp":1790618445308,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1999,6,29]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>\u2014Primary pulmonary hypertension results from progressive narrowing of the precapillary pulmonary vasculature. A variety of endothelial abnormalities have been identified, including a net reduction in pulmonary clearance of the vasoconstrictor and smooth muscle mitogen endothelin-1. In many patients, net pulmonary release of endothelin-1 is observed. Chronic infusions of epoprostenol (prostacyclin) improve functional capacity, survival, and hemodynamics in patients with advanced primary pulmonary hypertension. We hypothesized that the epoprostenol infusions, as compared with conventional therapy, might alter the abnormal pulmonary endothelin-1 homeostasis.<\/jats:p><jats:p><jats:italic>Methods and Results<\/jats:italic>\u2014Using a subset of patients from a larger randomized study comparing epoprostenol plus conventional therapy (n=11 in the present study) with conventional therapy alone (n=7 in the present study), we determined the ratio of plasma endothelin-1 levels in systemic arterial blood leaving the lung to levels in mixed venous blood entering the lung both before randomization and after 88 days of continuous therapy. There were no differences between the 2 groups before therapy, but by day 88, the epoprostenol-treated group had a greater proportion of patients (82%) with an arterial\/venous ratio &lt;1 than did the conventional therapy group, in which only 29% of patients had a ratio &lt;1 (<jats:italic>P<\/jats:italic>&lt;0.05).<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>\u2014These results suggest that continuous epoprostenol therapy may have a beneficial effect on the balance between endothelin-1 clearance and release in many patients with primary pulmonary hypertension and may provide one explanation for the salutary effect of epoprostenol in this disease.<\/jats:p>","DOI":"10.1161\/01.cir.99.25.3266","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:42:29Z","timestamp":1339461749000},"page":"3266-3271","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Continuous Infusion of Epoprostenol Improves the Net Balance Between Pulmonary Endothelin-1 Clearance and Release in Primary Pulmonary Hypertension"],"prefix":"10.1161","volume":"99","author":[{"given":"David","family":"Langleben","sequence":"first","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn J.","family":"Barst","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Badesch","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertron M.","family":"Groves","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor F.","family":"Tapson","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murali","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Bourge","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ettinger","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Shalit","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Clayton","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Jo\u0308bsis","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelmer D.","family":"Blackburn","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Crow","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walker","family":"Long","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada (D.L., E.S.); College of Physicians and Surgeons, Columbia University, New York, NY (R.J.B.); University of Colorado Health Sciences Center, Denver, Colo (D.B., B.M.G.); Duke University Medical Center, Durham, NC (V.F.T.); Presbyterian University Hospital, Pittsburgh, Pa (S.M.); University of Alabama, Birmingham, Ala (R.C.B.); Washington University, St. Louis, Mo (N.E.); Glaxo Wellcome Inc, Research..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701093360207"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1910"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207093270202"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.6.9804054"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330403"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332416"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-6-464"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0"},{"key":"e_1_3_2_9_2","first-page":"150","volume":"1","year":"1989","unstructured":"Dubin D, Pratt RE, Dzau VJ. Endothelin, a potent vasoconstrictor, is a smooth muscle mitogen. J Vasc Biol Med. 1989;1:150\u2013154.","journal-title":"J Vasc Biol Med"},{"key":"e_1_3_2_10_2","first-page":"L95","volume":"268","year":"1995","unstructured":"Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, Chen YF. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol. 1995;268:L95\u2013L100.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115367"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0022-3565(24)36925-3","volume":"282","year":"1997","unstructured":"Prie S, Leung TK, Cernacek P, Ryan JW, Dupuis J. The orally active ET(A) receptor antagonist LU135252 prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats. J Pharmacol Exp Ther. 1997;282:1312\u20131318.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.24.9797"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.7.1578"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306173282402"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.70.4.366"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340504"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380501"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.6.1479"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00187-3"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2701"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-216"},{"key":"e_1_3_2_23_2","unstructured":"Snedecor GW Cochran WG eds. Statistical Methods. 8th ed. Ames Iowa: Iowa State Press; 1989:127."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92636-3"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.2.1735147"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32663-7"},{"key":"e_1_3_2_27_2","first-page":"H1342","volume":"270","year":"1996","unstructured":"Razandi M, Pedram A, Rubin T, Levin ER. PGE2 and PGI2 inhibit ET-1 secretion from endothelial cells by stimulating particulate guanylate cyclase. Am J Physiol. 1996;270:H1342\u2013H1349.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1996.81.4.1510"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(05)80036-4"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1646"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653857"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.9.2782"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.99.25.3266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:34:35Z","timestamp":1743370475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.99.25.3266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6,29]]},"references-count":32,"journal-issue":{"issue":"25","published-print":{"date-parts":[[1999,6,29]]}},"alternative-id":["10.1161\/01.CIR.99.25.3266"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.99.25.3266","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6,29]]},"assertion":[{"value":"1998-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-04-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}